Comprehensive genomic and immune profiling of non-small cell lung cancer brain metastases reveals low tumor inflammation and elevated cancer testis antigen burden | Labcorp Oncology Skip to main contentScroll Back to Top
Our global life sciences company brings diagnostic testing & drug development together.
Comprehensive genomic and immune profiling of non-small cell lung cancer brain metastases reveals low tumor inflammation and elevated cancer testis antigen burden
Poster
Comprehensive genomic and immune profiling of non-small cell lung cancer brain metastases reveals low tumor inflammation and elevated cancer testis antigen burden